This Section has focused on the role of Ca++ as a regulator of gene expression and cellular physiology. Using CAI as a tool, we have investigated Ca++-regulated molecular events. Several clones were identified from a subtractive hybridization of CAI-resistant v. wild type A2058 human melanoma cells. CAIR-1 is a unique 2.8kb about 62kDa cytoplasmic protein. It is overexpressed 2-4 fold in resistant cells not amplified; expression is not increased with short term exposure to CAI. CAIR-1 is expressed ubiquitously in tissue, with phylogenetic expression limited to higher eukaryotes. The expressed native protein is about 76kDa; the size difference is attributed in part to basal phosphorylation, documented by in vivo phosphorylation assays. CAIR-1 has both CKII and protein kinase C phosphorylation sites, and a single tyrosine phosphorylation site. It has an N-terminal leucine zipper and a proline-rich domain. Our studies suggest that CAIR-1 is a substrate for a PMA-insensitive protein kinase C. Further characterization of structure and function are ongoing. A second approach to the effect of Ca++ on gene regulation has used CAI as a tool to differentiate between a requirement for increased intracellular Ca++ and the source: intracellular release v. influx. Fos has long been known to require Ca++, but our recent collaborative studies have indicated that either influx or intracellular release may provide Ca++ to induce fos expression, depending upon the specific ligand. In RAT-1 cells expressing a fos-CAT construct, endothelin-1 can induce expression through either influx or intracellular release, however, EGF induction requires influx. Similarly, expression of matrix metalloproteinase-1 and -2 expression is inhibited by CAI. Fos is involved in MMP-1 transcription though AP-1 complex; the Ca++-sensitive transcription factor for MMP-2 has not been defined. We hypothesize that Ca++ balance in the cell may be altered by increasing Ca++ channel number. The only identified and cloned nonvoltage-gated Ca++ channel is the human homolog of trp, a Drosophila photoreceptor protein. Collaboratively, we are attempting to express this htrp homolog in both normal and malignant cells to determine how overexpression alters Ca++ homeostasis, and transformed and metastatic phenotypes. The htrp genes cloned are from normal human brain cDNA libraries and expression is restricted to brain. Homology is low between brain htrp genes, suggesting a family of related but independent trp genes. Cloning of a human trp homolog from breast and ovarian cancer cells is ongoing.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC009163-09
Application #
2464494
Study Section
Special Emphasis Panel (LP)
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Rasool, Nabila; LaRochelle, William; Zhong, Haihong et al. (2010) Secretory leukocyte protease inhibitor antagonizes paclitaxel in ovarian cancer cells. Clin Cancer Res 16:600-9
Kassis, Jareer N; Virador, Victoria M; Guancial, Elizabeth A et al. (2009) Genomic and phenotypic analysis reveals a key role for CCN1 (CYR61) in BAG3-modulated adhesion and invasion. J Pathol 218:495-504
Virador, Victoria M; Davidson, Ben; Czechowicz, Josephine et al. (2009) The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome. PLoS One 4:e5136
Elstrand, Mari Bunkholt; Kleinberg, Lilach; Kohn, Elise C et al. (2009) Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Int J Gynecol Pathol 28:211-21
Gunn, Andrew J; Hama, Yukihiro; Koyama, Yoshinori et al. (2007) Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore. Cancer Sci 98:1727-33
Davidson, Ben; Espina, Virginia; Steinberg, Seth M et al. (2006) Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin Cancer Res 12:791-9
Kassis, Jareer N; Guancial, Elizabeth A; Doong, Howard et al. (2006) CAIR-1/BAG-3 modulates cell adhesion and migration by downregulating activity of focal adhesion proteins. Exp Cell Res 312:2962-71
Kassis, Jareer; Klominek, Julius; Kohn, Elise C (2005) Tumor microenvironment: what can effusions teach us? Diagn Cytopathol 33:316-9
Kamrava, Mitchell; Simpkins, Fiona; Alejandro, Emilyn et al. (2005) Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer. Oncogene 24:7084-93
Perabo, Frank G E; Demant, Andre W; Wirger, Andreas et al. (2005) Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model. Anticancer Res 25:725-9

Showing the most recent 10 out of 22 publications